| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $7.0M | -70.1% |
| R&D Expense | $294.7M | +127.5% |
| SG&A Expense | $39.3M | +38.8% |
| Operating Income | -$327.0M | -143.2% |
| Income Tax | $0 | — |
| Net Income | -$274.5M | -143.0% |
| EPS (Basic) | -$3.36 | -71.4% |
| EPS (Diluted) | -$3.36 | -71.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $84.4M | -46.3% |
| Short-term Investments | $591.9M | +60.8% |
| Accounts Receivable | $3K | -83.3% |
| Current Assets | $689.7M | +29.5% |
| Total Assets | $1.12B | +73.1% |
| Current Liabilities | $46.1M | +70.0% |
| Total Liabilities | $64.9M | +130.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$247.6M | -114.9% |
| Capital Expenditures | $3.9M | +62.9% |
| Investing Cash Flow | -$502.6M | -217.2% |
| Financing Cash Flow | $677.6M | +86.8% |
| Free Cash Flow | -$251.4M | -113.8% |
| Stockholders' Equity |
| $1.06B |
| +70.5% |